Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LIXT
#3737
Lixte Biotechnology Holdings, Inc. Common Stock
2.9
0
-2.68%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-2.68%
Mudança mensal
-15.20%
Mudança em 6 meses
-15.20%
Mudança anual
+110.14%
Fechamento anterior
2.9
8
Open
2.8
9
Bid
Ask
Low
2.8
5
High
2.9
4
Volume
20
Mercados
Ações
Cuidados de saúde
LIXT
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
1.35 M
1.37 M
1.67 M
2.25 M
2.68 M
—
Valuation ratios
Enterprise value
—
—
—
4.45 M
7.91 M
45.66 M
Price to earnings ratio
—
—
—
-0.86
-1.28
-7.08
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
-1.02
-1.44
-9.3
Price to book ratio
—
—
—
8.87
-1.71
-5.68
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.62
-1.32
-1.14
-1.18
-3.13
-2.02
Return on equity %
0.65
-1.4
-1.22
-1.27
-4.33
-2.95
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
24.15
16.81
14.08
13.73
3.6
17.65
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-2.92
-2.24
-1.41
-0.93
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
3.38
2.19
0.46
1.77
Net current asset value per share
—
—
3.51
2.25
0.51
2.58
Tangible book value per share
—
—
1.05
0.26
-1.19
-1.26
Working capital per share
—
—
3.26
2.09
0.37
1.95
Book value per share
—
—
1.05
0.26
-1.19
-1.26
Notícias
LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary
LIXTE expands clinical trial for ovarian cancer treatment
Ações da Lixte Biotechnology caem após oferta direta de US$ 4,3 milhões
Spartan Capital atua como agente de colocação na oferta de US$ 4,3 milhões da Lixte
Lixte Biotechnology stock falls after $4.3 million direct offering
Spartan Capital acts as placement agent in Lixte’s $4.3 million offering
Ação da Lixte Biotechnology cai após oferta direta de US$ 4,3 milhões
Lixte Biotechnology stock falls after $4.3 million direct offering
Lixte Biotechnology raises $4.3 million in registered direct offering
Acionistas da Lixte Biotechnology aprovam indicados ao conselho e alteração no plano de ações
Lixte Biotechnology shareholders approve board nominees and stock plan amendment
Ações da Lixte Biotechnology caem após aquisição da britânica Liora